Synapse - Andrew Dunbar

Results (44)

Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms

Research Letter

Shank, K.; Dunbar, A.; Koppikar, P.; Kleppe, M.; Teruya-Feldstein, J.; Csete, I.; Bhagwat, N.; Keller, M.; Kilpivaara, O.; Michor, F.; more...
Haematologica (2020)

Fulltext@MSK | Save

Detection of marker-free precision genome editing and genetic variation through the capture of genomic signatures

Journal Article

Billon, P.; Nambiar, T. S.; Hayward, S. B.; Zafra, M. P.; Schatoff, E. M.; Oshima, K.; Dunbar, A.; Breinig, M.; Park, Y. C.; Ryu, H. S.; more...
Cell Reports (2020)

Fulltext@MSK | Save

ETV6: A candidate gene for predisposition to "blend pedigrees"? A case report from the NEXT-Famly clinical trial

Journal Article

Bernardi, S.; Farina, M.; Zanaglio, C.; Cattina, F.; Polverelli, N.; Schieppati, F.; Re, F.; Foroni, C.; Malagola, M.; Dunbar, A. J.; more...
Case Reports in Hematology (2020)

Fulltext@MSK | Save

Aberrant responsiveness of erythropoiesis to iron deficiency in polycythemia vera

Meeting Abstract

Feola, M.; Moskop, D.; Terra, N.; Park, Y. C.; Dunbar, A.; Levine, R. L.; Hoffman, R.; Ginzburg, Y.
Blood (2019)

Fulltext@MSK | Save

Comparative somatic mutational profiling of CD34+ hematopoietic precursors (HSC) and circulating endothelial cells (CEC) in patients with primary myelofibrosis (PMF)

Meeting Abstract

Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; Malagola, M.; Re, F.; Cattina, F.; D'Adda, M.; Rossi, G.; Zollner, T.; more...
Blood (2019)

Fulltext@MSK | Save

Identifying cytokine biomarkers of response to pegylated-interferon therapy in polycythemia vera and essential thrombocythemia: Correlative analysis from the MPN-RC 111/112 trials

Meeting Abstract

Dunbar, A.; Kosiorek, H. E.; Krishnan, A.; McGovern, E.; Park, Y.; Patel, M. A.; Singer Weinberg, R.; Yacoub, A.; Dueck, A. C.; Mascarenhas, J.; more...
Blood (2019)

Fulltext@MSK | Save

Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy

Meeting Abstract

Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
Blood (2019)

Fulltext@MSK | Save

RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy

Meeting Abstract

Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
Blood (2019)

Fulltext@MSK | Save

RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy